Chemical Compound Review:
Haldol 4-[4-(4-chlorophenyl)-4- hydroxy-1...
Synonyms:
Brotopon, Eukystol, Fortunan, Halojust, Halosten, ...
- Treatment and prognosis of hemiballismus. Klawans, H.L., Moses, H., Nausieda, P.A., Bergen, D., Weiner, W.J. N. Engl. J. Med. (1976)
- Pavlovian conditional tolerance to haloperidol catalepsy: evidence of dynamic adaptation in the dopaminergic system. Poulos, C.X., Hinson, R. Science (1982)
- Dyskinesias evoked in monkeys by weekly administration of haloperidol. Weiss, B., Santelli, S. Science (1978)
- Haloperidol for organic brain disorders. Davis, J.A. JAMA (1979)
- Haloperidol-induced chronic cholestatic liver disease. Dincsoy, H.P., Saelinger, D.A. Gastroenterology (1982)
- A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. Csernansky, J.G., Mahmoud, R., Brenner, R. N. Engl. J. Med. (2002)
- Low-dose haloperidol for stereotypic self-injurious behavior in the mentally retarded. Mikkelsen, E.J. N. Engl. J. Med. (1986)
- Transdermal nicotine patch and potentiation of haloperidol in Tourette's syndrome. Silver, A.A., Sanberg, P.R. Lancet (1993)
- Akathisia with haloperidol and thiothixene. Van Putten, T., May, P.R., Marder, S.R. Arch. Gen. Psychiatry (1984)
- Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study. Klein, E., Bental, E., Lerer, B., Belmaker, R.H. Arch. Gen. Psychiatry (1984)
- Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Csomor, P.A., Stadler, R.R., Feldon, J., Yee, B.K., Geyer, M.A., Vollenweider, F.X. Neuropsychopharmacology (2008)
- Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Emamian, E.S., Hall, D., Birnbaum, M.J., Karayiorgou, M., Gogos, J.A. Nat. Genet. (2004)
- Neurotensin blocks certain amphetamine-induced behaviours. Ervin, G.N., Birkemo, L.S., Nemeroff, C.B., Prange, A.J. Nature (1981)
- Perinatal dopamine-related drugs demasculinize rats. Hull, E.M., Nishita, J.K., Bitran, D., Dalterio, S. Science (1984)
- Haloperidol-induced plasticity of axon terminals in rat substantia nigra. Benes, F.M., Paskevich, P.A., Domesick, V.B. Science (1983)
- Dementia induced by methyldopa with haloperidol. Thornton, W.E. N. Engl. J. Med. (1976)
- Comparison of pimozide with haloperidol in Gilles de la Tourette syndrome. Rose, M.S., Moldofsky, H. Lancet (1977)
- Nicotine gum and haloperidol in Tourette's syndrome. Sanberg, P.R., Fogelson, H.M., Manderscheid, P.Z., Parker, K.W., Norman, A.B., McConville, B.J. Lancet (1988)
- Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder. Campbell, M., Small, A.M., Green, W.H., Jennings, S.J., Perry, R., Bennett, W.G., Anderson, L. Arch. Gen. Psychiatry (1984)
- Clonidine and haloperidol in Gilles de la Tourette syndrome. Shapiro, A.K., Shapiro, E. Arch. Gen. Psychiatry (1981)
- Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats. Rosengarten, H., Friedhoff, A.J. Science (1979)
- Limb malformations following maternal use of haloperidol. McCullar, F.W., Heggeness, L. JAMA (1975)
- The sigma enigma: biochemical and functional correlates emerge for the haloperidol-sensitive sigma binding site. Chavkin, C. Trends Pharmacol. Sci. (1990)
- Plasma norepinephrine and dopamine-beta-hydroxylase activity in schizophrenia. Castellani, S., Ziegler, M.G., van Kammen, D.P., Alexander, P.E., Siris, S.G., Lake, C.R. Arch. Gen. Psychiatry (1982)
- Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. Kane, J.M., Marder, S.R., Schooler, N.R., Wirshing, W.C., Umbricht, D., Baker, R.W., Wirshing, D.A., Safferman, A., Ganguli, R., McMeniman, M., Borenstein, M. Arch. Gen. Psychiatry (2001)
- Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Feeney, D.M., Gonzalez, A., Law, W.A. Science (1982)
- The antiinflammatory effect of dopamine in alcoholic hemorrhagic pancreatitis in cats. Studies on the receptors and mechanisms of action. Karanjia, N.D., Widdison, A.L., Lutrin, F.J., Chang, Y.B., Reber, H.A. Gastroenterology (1991)
- Central neurotensin inhibits gastric acid secretion: an adrenergic mechanism in rats. Zhang, L., Xing, L.P., Demers, L., Washington, J., Kauffman, G.L. Gastroenterology (1989)
- Effect of dopamine on the esophageal smooth muscle in vivo. Rattan, S., Goyal, R.K. Gastroenterology (1976)
- Adverse reactions in treatment with lithium carbonate and haloperidol. Baastrup, P.C., Hollnagel, P., Sorensen, R., Schou, M. JAMA (1976)
- Haloperidol antagonism of cue-elicited cocaine craving. Berger, S.P., Hall, S., Mickalian, J.D., Reid, M.S., Crawford, C.A., Delucchi, K., Carr, K., Hall, S. Lancet (1996)
- Peptide YY inhibition of prostaglandin-induced intestinal secretion is haloperidol-sensitive in humans. Rozé, C., Molis, C., Xiaomei, F.C., Ropert, A., Genève, J., Galmiche, J.P. Gastroenterology (1997)
- Increased levels of transcription factors Elk-1, cyclic adenosine monophosphate response element-binding protein, and activating transcription factor 2 in the cerebellar vermis of schizophrenic patients. Kyosseva, S.V., Elbein, A.D., Hutton, T.L., Griffin, S.T., Mrak, R.E., Sturner, W.Q., Karson, C.N. Arch. Gen. Psychiatry (2000)
- Plasma homovanillic acid as a predictor of response to neuroleptics. Davila, R., Manero, E., Zumarraga, M., Andia, I., Schweitzer, J.W., Friedhoff, A.J. Arch. Gen. Psychiatry (1988)
- Evidence for in vivo interactions between neuropeptide Y-related peptides and sigma receptors in the mouse hippocampal formation. Bouchard, P., Dumont, Y., Fournier, A., St-Pierre, S., Quirion, R. J. Neurosci. (1993)
- Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Takahashi, M., Shirakawa, O., Toyooka, K., Kitamura, N., Hashimoto, T., Maeda, K., Koizumi, S., Wakabayashi, K., Takahashi, H., Someya, T., Nawa, H. Mol. Psychiatry (2000)
- Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients. Futamura, T., Toyooka, K., Iritani, S., Niizato, K., Nakamura, R., Tsuchiya, K., Someya, T., Kakita, A., Takahashi, H., Nawa, H. Mol. Psychiatry (2002)
- Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol. Ilyin, V.I., Whittemore, E.R., Guastella, J., Weber, E., Woodward, R.M. Mol. Pharmacol. (1996)
- Enhanced detection of receptor constitutive activity in the presence of regulators of G protein signaling: applications to the detection and analysis of inverse agonists and low-efficacy partial agonists. Welsby, P.J., Kellett, E., Wilkinson, G., Milligan, G. Mol. Pharmacol. (2002)
- Erythropoietin prevents haloperidol treatment-induced neuronal apoptosis through regulation of BDNF. Pillai, A., Dhandapani, K.M., Pillai, B.A., Terry, A.V., Mahadik, S.P. Neuropsychopharmacology (2008)
- Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Mohn, A.R., Gainetdinov, R.R., Caron, M.G., Koller, B.H. Cell (1999)
- A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Rosenheck, R., Cramer, J., Xu, W., Thomas, J., Henderson, W., Frisman, L., Fye, C., Charney, D. N. Engl. J. Med. (1997)
- Association of two pertussis toxin-sensitive G-proteins with the D2-dopamine receptor from bovine striatum. Elazar, Z., Siegel, G., Fuchs, S. EMBO J. (1989)
- Haloperidol for acute schizophrenic patients. An evaluation of three oral regimens. Donlon, P.T., Hopkin, J.T., Tupin, J.P., Wicks, J.J., Wahba, M., Meadow, A. Arch. Gen. Psychiatry (1980)